Bruker Wins FDA Clearance for MALDI Biotyper, Opening up US Clinical Market | GenomeWeb

Having last week received US Food and Drug Administration 510(k) clearance, Bruker's MALDI Biotyper is now approved for clinical microbiology work in the US.

With the clearance, the Biotyper joins its primary competitor, BioMérieux's Vitek MS system, which received 510(k) clearance in August. US hospitals and other facilities that have been waiting on FDA clearance to begin using the system can now implement it as part of their clinical workflows.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.